Erik Kramer, DO
Family Medicine · Westminster, CONPI 1215298062
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,120 of the $10,774 with a category attached, or 75.4%. 9 manufacturers reported payments, led by Insulet Corporation at 51.9% of the total. 2025 is the largest year on record at $5,142, more than ten times the $119 reported in 2019. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $291.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$6K
- Dexcom, Inc.$3K
- Novo Nordisk$780
- Sanofi$468
- Rhythm Pharmaceuticals, Inc.$247
- BETA Bionics, Inc.$197
- plus $146 from 3 others
Across 78 payments — averaging $1192.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sequel Med Tech, LLC$93K
What the payments were for
- Speaking & faculty fees$8,12075%
- Travel & lodging$4454%
- Food & beverage$2,21021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 7 | $5,595 |
| Dexcom, Inc. | 3 | $3,341 |
| Novo Nordisk | 13 | $780 |
| Sanofi | 8 | $468 |
| Rhythm Pharmaceuticals, Inc. | 2 | $247 |
| BETA Bionics, Inc. | 1 | $197 |
| Chiesi USA, Inc. | 1 | $112 |
| Abbott | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$5,595
- DEXCOM STELO GLUCOSE BIOSENSOR$3,341
- iLet Bionic Pancreas$590
- Imcivree$148
- LUMIZYME$119
- MYALEPT$112
How this compares
$10,774 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 46 | $46,953 |
| OzempicSemaglutide | 29 | $42,262 |
| JardianceEmpagliflozin | 19 | $32,504 |
| TrulicityDulaglutide | 23 | $31,814 |
| RybelsusSemaglutide | 11 | $23,793 |
| EliquisApixaban | 21 | $23,765 |
| Atorvastatin Calcium | 132 | $1,327 |
| Telmisartan | 31 | $1,155 |
| Levothyroxine Sodium | 78 | $1,120 |
| Gabapentin | 41 | $1,084 |
| Potassium Chloride | 15 | $945 |
| Omeprazole | 45 | $860 |
| Pregabalin | 12 | $778 |
| Celecoxib | 11 | $723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $655 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $780 | $66,05440 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Westminster
- Gregory MaederWestminster$95K
- Marilyn NguyenWestminster$12K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.